Life Sciences Virtual Investor Forum to Showcase Over 20 Public Companies on June 24-25, Co-Hosted by Zacks Small-Cap Research

The Life Sciences Virtual Investor Forum, a B2i Digital Featured Conference co-hosted by Virtual Investor Conferences and Zacks Small-Cap Research, is scheduled for June 24 and 25, 2026. The event will feature live presentations and real-time Q&A sessions from over 20 public companies spanning biotechnology, diagnostics, medical devices, digital health, and related sectors. B2i Digital, Inc., serving as the Official Marketing Partner, will leverage its distribution and media engine to promote the forum to a proprietary network of more than 1.7 million retail and institutional market participants.

Zacks Small-Cap Research, a preferred provider in the OTC Markets Group's Research Marketplace, co-hosts the forum and brings independent company-sponsored research to the event. According to the press release, the two-day lineup includes clinical-stage biotechnology firms, rare-disease and oncology therapeutics developers, molecular diagnostics companies, medical device manufacturers, veterinary medicine specialists, nutrition science innovators, and AI-powered digital health platforms.

Each presenting company will have 30 minutes for a live presentation followed by a Q&A session. Investors can request one-on-one meetings with management teams through the Virtual Investor Conferences platform. Replays of the presentations will be available on B2i Digital and OTC Markets YouTube channels.

David Shapiro, Chief Executive Officer of B2i Digital, emphasized the value of direct access: "Life sciences investors want efficient, direct access to management teams developing the therapies and technologies that matter, and pairing that access with independent research from Zacks makes the forum more valuable on both sides."

The presenting companies as of June 17, 2026, include Protalix BioTherapeutics, MetaVia Inc., CytoSorbents Corporation, PetVivo Holdings, Jaguar Health, Reviva Pharmaceuticals, 4DMedical, Prostatype Genomics, Abingdon Health, Innovotech, Lakewood-Amedex Biotherapeutics, Nasus Pharma, Kelyniam Global, IMUNON, Promino Nutritional Sciences, Envoy Medical, Coiled Therapeutics, Aspire Biopharma Holdings, Rocket Doctor AI, Phio Pharmaceuticals, aTyr Pharma, and NuFarm.

Registration and company profiles are available at the Virtual Investor Conferences website. To request one-on-one meetings, investors can use the following link: Axle Access meeting request.

Virtual Investor Conferences is a property of OTC Markets Group Inc. and features public companies from exchanges worldwide, including NYSE, Nasdaq, TSX, TSXV, CSE, ASX, LSE, and the OTC Markets. B2i Digital, founded in 2021 by David Shapiro, partners with investor conferences, public companies, and capital markets advisors through its Featured Conference, Featured Company, and Featured Expert programs.

The forum underscores the growing trend of virtual investor events that provide efficient, direct engagement between management teams and investors, particularly in the life sciences sector where specialized knowledge and timely access to developments are critical.